Gastrointestinal Stromal Tumor (GIST) Drug -India Market Status and Trend Report 2013-2023
Report Summary
Gastrointestinal Stromal Tumor (GIST) Drug -India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Gastrointestinal Stromal Tumor (GIST) Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole India and Regional Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017, and development forecast 2018-2023
Main market players of Gastrointestinal Stromal Tumor (GIST) Drug in India, with company and product introduction, position in the Gastrointestinal Stromal Tumor (GIST) Drug market
Market status and development trend of Gastrointestinal Stromal Tumor (GIST) Drug by types and applications
Cost and profit status of Gastrointestinal Stromal Tumor (GIST) Drug, and marketing status
Market growth drivers and challenges
The report segments the India Gastrointestinal Stromal Tumor (GIST) Drug market as:
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North India
Northeast India
East India
South India
West India
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinic
Hospital
Others
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Players Segment Analysis (Company and Product introduction, Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price and Gross Margin):
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gastrointestinal Stromal Tumor (GIST) Drug -India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Gastrointestinal Stromal Tumor (GIST) Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole India and Regional Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2017, and development forecast 2018-2023
Main market players of Gastrointestinal Stromal Tumor (GIST) Drug in India, with company and product introduction, position in the Gastrointestinal Stromal Tumor (GIST) Drug market
Market status and development trend of Gastrointestinal Stromal Tumor (GIST) Drug by types and applications
Cost and profit status of Gastrointestinal Stromal Tumor (GIST) Drug, and marketing status
Market growth drivers and challenges
The report segments the India Gastrointestinal Stromal Tumor (GIST) Drug market as:
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North India
Northeast India
East India
South India
West India
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinic
Hospital
Others
India Gastrointestinal Stromal Tumor (GIST) Drug Market: Players Segment Analysis (Company and Product introduction, Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price and Gross Margin):
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug in This Report
1.2 Commercial Types of Gastrointestinal Stromal Tumor (GIST) Drug
1.2.1 Amcasertib
1.2.2 Anagrelide hydrochloride CR
1.2.3 APG-1351
1.2.4 Binimetinib
1.2.5 Others
1.3 Downstream Application of Gastrointestinal Stromal Tumor (GIST) Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Development History of Gastrointestinal Stromal Tumor (GIST) Drug
1.5 Market Status and Trend of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2023
1.5.1 India Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Gastrointestinal Stromal Tumor (GIST) Drug in India 2013-2017
2.2 Consumption Market of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.2.1 Consumption Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.2.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.3 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.3.1 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in North India 2013-2017
2.3.2 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in Northeast India 2013-2017
2.3.3 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in East India 2013-2017
2.3.4 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in South India 2013-2017
2.3.5 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in West India 2013-2017
2.4 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India 2017-2023
2.4.1 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India 2017-2023
2.4.2 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Regions 2017-2023
CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
3.1.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Downstream Industry
4.2 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in Major Countries
4.2.1 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in North India
4.2.2 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in Northeast India
4.2.3 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in East India
4.2.4 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in South India
4.2.5 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in West India
4.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
5.1 India Economy Situation and Trend Overview
5.2 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA
6.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Major Players
6.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Major Players
6.3 Basic Information of Gastrointestinal Stromal Tumor (GIST) Drug by Major Players
6.3.1 Headquarters Location and Established Time of Gastrointestinal Stromal Tumor (GIST) Drug Major Players
6.3.2 Employees and Revenue Level of Gastrointestinal Stromal Tumor (GIST) Drug Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Company profile
7.1.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.1.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Ariad Pharmaceuticals, Inc.
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Company profile
7.2.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Arog Pharmaceuticals, Inc.
7.3 Array BioPharma Inc.
7.3.1 Company profile
7.3.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.3.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Array BioPharma Inc.
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Company profile
7.4.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Astex Pharmaceuticals, Inc.
7.5 Blueprint Medicines Corporation
7.5.1 Company profile
7.5.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Blueprint Medicines Corporation
7.6 Boston Biomedical, Inc.
7.6.1 Company profile
7.6.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Boston Biomedical, Inc.
7.7 Calithera Biosciences, Inc.
7.7.1 Company profile
7.7.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.7.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Calithera Biosciences, Inc.
7.8 Chipscreen Biosciences Ltd
7.8.1 Company profile
7.8.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.8.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences Ltd
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Company profile
7.9.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.9.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Deciphera Pharmaceuticals, LLC
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 Company profile
7.10.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.10.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
7.11 Horizon Pharma Plc
7.11.1 Company profile
7.11.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.11.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Horizon Pharma Plc
7.12 Immunicum AB
7.12.1 Company profile
7.12.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.12.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Immunicum AB
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Company profile
7.13.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.13.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine Co., Ltd.
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Company profile
7.14.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.14.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Kolltan Pharmaceuticals, Inc.
7.15 Natco Pharma Limited
7.15.1 Company profile
7.15.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.15.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Natco Pharma Limited
7.16 Nerviano Medical Sciences S.r.l.
7.17 Novartis AG
7.18 Omeros Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
8.1 Industry Chain of Gastrointestinal Stromal Tumor (GIST) Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
9.1 Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.2 Raw Materials Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.3 Labor Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.4 Manufacturing Expenses Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug in This Report
1.2 Commercial Types of Gastrointestinal Stromal Tumor (GIST) Drug
1.2.1 Amcasertib
1.2.2 Anagrelide hydrochloride CR
1.2.3 APG-1351
1.2.4 Binimetinib
1.2.5 Others
1.3 Downstream Application of Gastrointestinal Stromal Tumor (GIST) Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Development History of Gastrointestinal Stromal Tumor (GIST) Drug
1.5 Market Status and Trend of Gastrointestinal Stromal Tumor (GIST) Drug 2013-2023
1.5.1 India Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Trend 2013-2023
CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Gastrointestinal Stromal Tumor (GIST) Drug in India 2013-2017
2.2 Consumption Market of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.2.1 Consumption Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.2.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.3 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in India by Regions
2.3.1 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in North India 2013-2017
2.3.2 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in Northeast India 2013-2017
2.3.3 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in East India 2013-2017
2.3.4 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in South India 2013-2017
2.3.5 Market Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in West India 2013-2017
2.4 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India 2017-2023
2.4.1 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India 2017-2023
2.4.2 Market Development Forecast of Gastrointestinal Stromal Tumor (GIST) Drug by Regions 2017-2023
CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
3.1.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India by Types
CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Downstream Industry
4.2 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in Major Countries
4.2.1 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in North India
4.2.2 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in Northeast India
4.2.3 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in East India
4.2.4 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in South India
4.2.5 Demand Volume of Gastrointestinal Stromal Tumor (GIST) Drug by Downstream Industry in West India
4.3 Market Forecast of Gastrointestinal Stromal Tumor (GIST) Drug in India by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
5.1 India Economy Situation and Trend Overview
5.2 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA
6.1 Sales Volume of Gastrointestinal Stromal Tumor (GIST) Drug in India by Major Players
6.2 Revenue of Gastrointestinal Stromal Tumor (GIST) Drug in India by Major Players
6.3 Basic Information of Gastrointestinal Stromal Tumor (GIST) Drug by Major Players
6.3.1 Headquarters Location and Established Time of Gastrointestinal Stromal Tumor (GIST) Drug Major Players
6.3.2 Employees and Revenue Level of Gastrointestinal Stromal Tumor (GIST) Drug Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Company profile
7.1.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.1.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Ariad Pharmaceuticals, Inc.
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Company profile
7.2.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Arog Pharmaceuticals, Inc.
7.3 Array BioPharma Inc.
7.3.1 Company profile
7.3.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.3.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Array BioPharma Inc.
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Company profile
7.4.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Astex Pharmaceuticals, Inc.
7.5 Blueprint Medicines Corporation
7.5.1 Company profile
7.5.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Blueprint Medicines Corporation
7.6 Boston Biomedical, Inc.
7.6.1 Company profile
7.6.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Boston Biomedical, Inc.
7.7 Calithera Biosciences, Inc.
7.7.1 Company profile
7.7.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.7.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Calithera Biosciences, Inc.
7.8 Chipscreen Biosciences Ltd
7.8.1 Company profile
7.8.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.8.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences Ltd
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Company profile
7.9.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.9.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Deciphera Pharmaceuticals, LLC
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 Company profile
7.10.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.10.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd.
7.11 Horizon Pharma Plc
7.11.1 Company profile
7.11.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.11.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Horizon Pharma Plc
7.12 Immunicum AB
7.12.1 Company profile
7.12.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.12.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Immunicum AB
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Company profile
7.13.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.13.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine Co., Ltd.
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Company profile
7.14.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.14.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Kolltan Pharmaceuticals, Inc.
7.15 Natco Pharma Limited
7.15.1 Company profile
7.15.2 Representative Gastrointestinal Stromal Tumor (GIST) Drug Product
7.15.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of Natco Pharma Limited
7.16 Nerviano Medical Sciences S.r.l.
7.17 Novartis AG
7.18 Omeros Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
8.1 Industry Chain of Gastrointestinal Stromal Tumor (GIST) Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
9.1 Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.2 Raw Materials Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.3 Labor Cost Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
9.4 Manufacturing Expenses Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
